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Abstract. 
 
Mutations in the genes for presenilin 1 and 2 
(PS-1 and PS-2) have been linked to development of 
early-onset Alzheimer’s disease (AD). As neither the 
normal function of either presenilin is known nor why 
mutations cause disease, we examined the properties of 
wild-type, truncated, and mutant PS-2 upon expression 
in HeLa cells. Although HeLa cells are strongly predis-
posed to continued mitosis, expression of PS-2 induced 
programmed cell death (apoptosis). Direct evidence for 
apoptosis was obtained by double staining for terminal 
deoxynucleotide transferase nick end labeling 
(TUNEL) and PS-2 expression and by following green 
fluorescent protein–tagged PS-2 over time. Deletion 
 
analysis indicates that as little as 166 NH
 
2
 
-terminal resi-
dues of PS-2 are sufficient for endoplasmic reticulum 
(ER) localization and apoptosis. Moreover, the AD-
associated PS-2 missense mutation (N141I) more effi-
ciently induced cell death compared to wild-type PS-2 
despite lower mutant protein accumulation. Expression 
of the presenilins in several other cell lines and trans-
genic mice has been accompanied by rapid protein 
cleavage without the induction of cell death. In con-
trast, PS-2 expressed in HeLa cells was not cleaved, and 
cell death occurred. We hypothesize that full-length but 
not cleaved PS-2 may be important in the regulation or 
induction of apoptosis.
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1. 
 
Abbreviations used in this paper
 
: aa, amino acid(s); AD, Alzheimer’s
disease; 
 
b
 
APP, 
 
b
 
-amyloid precursor protein gene; CMV, cytomegalovirus;
DAPI, 4
 
9
 
6-diamidino-2-phenylindole; GST, glutathione-S-transferase; PS-1
and -2, presenilin 1 and 2; TMD, transmembrane domain.
 
A
 
lzheimer’s 
 
disease (AD)
 
1
 
 is a neurodegenerative dis-
order manifesting with increasing incidence in the
aging population. Clinically, it is characterized by
memory loss and declining cognitive functions. Familial
studies, especially in early-onset cases, indicate molecular
heterogeneity and have linked AD to mutations in at least
three genes: the 
 
b
 
-amyloid precursor protein gene (
 
b
 
APP)
located on chromosome 21 (for review see Mullan and
Crawford, 1993) and the presenilin 1 and 2 (PS-1 and PS-2,
respectively) genes located on chromosome 14 and 1, re-
spectively (Alzheimer’s Disease Collaborative Group, 1995;
Campion et al., 1995; Chapman et al., 1995; Cruts et al.,
1995; Levy-Lahad et al., 1995
 
a
 
,
 
b
 
; Perez-Tur et al., 1995;
Rogaev et al., 1995; Sherrington et al., 1995; Wasco et al.,
1995; Boteva et al., 1996). In addition, there is evidence
that the acquisition of the apolipoprotein E type 4 (APOE-
E4) allele on chromosome 19 predisposes individuals to
early onset of AD (Corder et al., 1993; Strittmatter and
Roses, 1995).
Mutations in 
 
b
 
APP account for 
 
z
 
5% of familial cases
(
 
z
 
19 families) with six different single or double missense
mutations described so far (for review see Haass et al.,
1995; Van Broeckhoven, 1995). The larger proportion of
familial AD patients (50–70% of all cases 
 
.
 
50 families)
have mutations within the PS-1 gene, which has been
shown to be a hot spot for missense mutations, as greater
than 35 different mutations have been identified so far (for
review see Cruts et al., 1996; Haass, 1997). Interestingly,
the age of onset of AD correlates somewhat with the loca-
tion of mutations within the coding regions of PS-1 (for re-
view see Cruts et al., 1996). Fewer AD cases are associated
with mutations in PS-2 as only two missense mutations
have been described in eight families, mainly of Volga-Ger-
man descent (Levy-Lahad et al., 1995
 
a
 
,
 
b
 
; Rogaev et al.,
1995), and recent evidence indicates at least one of these
mutations is variably penetrant (Sherrington et al., 1996).
PS-1 and PS-2 are highly homologous by sequence com-
parison with the highest degrees of variability occurring in
the amino- and carboxyl-terminal regions. Although the
function of these proteins is not known, they share homol-
ogy with two 
 
Caenorhabditis elegans
 
 proteins. The prese-
nilins are 
 
z
 
50% homologous to Sel-12, which is involved
in cell signaling by Notch-based receptors, and they ex-
hibit limited homology to SPE-4, which functions in sper-
matogenesis (Levitan and Greenwald, 1995; Levy-Lahad
et al., 1995; Sherrington et al., 1995). Evidence suggesting
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that these putative 
 
C. elegans
 
 homologues may indeed be
related to mammalian presenilins is the apparent ability of
injected human PS-1 and PS-2 cDNAs to functionally res-
cue a 
 
C. elegans
 
 Sel-12 mutant defective in vulva develop-
ment and egg laying (Levitan et al., 1996). Additional evi-
dence indicating PS involvement in development are
recent reports showing molecular disruption of the PS-1
gene leads to death shortly after birth with embryos dis-
playing central nervous system defects together with ab-
normal patterning of the axial skeleton and spinal ganglia
(Shen et al., 1997; Wong et al., 1997).
Both presenilin genes are ubiquitously expressed with
differential accumulation of two major mRNA transcripts
(Li et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995;
Lee et al., 1996; Vito et al., 1996
 
a
 
,
 
b
 
). Immunofluorescence
staining of epitope-tagged presenilins indicates that the
proteins are localized to the ER and Golgi, although sub-
tle differences in localization between PS-1 and PS-2 were
noted (Cook et al., 1996; Kovacs et al., 1996; Walter et al.,
1996). The presenilins are multipass transmembrane pro-
teins that are believed to topologically weave through ER
membranes six to eight times with the NH
 
2
 
- and COOH-
terminal domains and the large “loop” spanning the puta-
tive sixth and seventh transmembrane domains (TMDs) (ac-
cording to some models) contained within the cytoplasm
(see Fig. 1; Doan et al., 1996; Li and Greenwald, 1996; Leh-
mann et al., 1997). Recent studies of PS-1 expression in
fibroblasts and transgenic mice indicate that PS-1 is pro-
teolytically cleaved since 27–28-kD NH
 
2
 
-terminal and 16–
17-kD COOH-terminal derivatives accumulate in cell ly-
sates (Lee et al., 1996; Thinakaran et al., 1996). Analogous
proteolytic cleavage of PS-2 has also been reported (Kim
et al., 1997; Tomita et al., 1997). The function of proteo-
lytic cleavage of the presenilins is not known.
To study the function of presenilins, we cloned and ex-
pressed wild-type, mutant, and deleted forms of human
PS-2 in HeLa cells, a human cell line typically resistant to
apoptosis. Our studies show that the overexpression of PS-2
in HeLa cells affects nuclear morphology and causes cell
death. Furthermore, we demonstrate that 166 NH
 
2
 
-termi-
nal PS-2 residues are sufficient for ER localization and for
inducing cell death. Most interestingly, we demonstrate the
AD-associated PS-2(N141I) mutation induces an increase
in cell death of HeLa cells compared to wild-type PS-2.
 
Materials and Methods
 
Cloning of Human PS-2 cDNA and Construction of
PS-2 Variants
 
The PS-2 cDNA was obtained from a human brain marathon-ready
cDNA library (CLONTECH Laboratories, Inc., Palo Alto, CA) by PCR
amplification using two primers, a 5
 
9
 
-end primer (5
 
9
 
ATCGATAAGCTT-
CGCGAGTGTTCGTGGTGCTTCCAGAGGCA3
 
9
 
) of which 25 bases
of the 3
 
9
 
 end of the primer were identical to the coding strand of human
PS-2 six bases upstream of the ATG start codon, and a 3
 
9
 
-end primer
(5
 
9
 
GGAAGAATTCGTCGACGCAGCCTGTGGCACACCATGTCCC3
 
9
 
)
 of which 24 bases of the 3
 
9
 
 end were complementary to sequences imme-
diately downstream of the PS-2 stop codon. The PCR reaction was carried
out according to instructions provided by the manufacturer. A major PCR
product of 
 
z
 
1.4-kbp spanning the entire coding sequence of PS-2 was pro-
duced. The PCR product was digested with EcoRI since this site was engi-
neered into the 3
 
9
 
-end primer and the resulting 
 
z
 
1.4-kbp product was li-
gated into plasmid pBluescript KS(
 
2
 
) that had been previously digested
 
with EcoRV and EcoRI. The recombinant plasmid was fully sequenced
and was found to correspond to human PS-2 without any of the known
AD mutations (Levy-Lahad et al., 1995
 
a
 
; Rogaev et al., 1995).
To express PS-2 in human cells, full-length PS-2 and four progressively
shorter COOH-terminal deletions were cloned into a pGEM expression
vector such that the PS-2 cDNA was placed in the appropriate orientation
for expression from the strong cytomegalovirus (CMV) promoter (Fig. 1).
The pGEM CMV-driven expression plasmid was constructed from pCMV-
NF-L (Lee et al., 1993; was kindly provided by Dr. Michael Lee, Johns
Hopkins University, Baltimore, MD) by first destroying the most 5
 
9
 
EcoRI site in the vector by standard molecular techniques. The product
was then double digested with EagI, which cleaves just 3
 
9
 
 of the CMV pro-
moter in NF-L 5
 
9
 
 untranslated sequences (see Monteiro et al., 1994), and
HindIII, which is located at the 3
 
9
 
 end of the NF-L fragment (Lee et al.,
1993). Next, through a series of cloning steps an EagI-HindIII fragment
from pNF(
 
1
 
La/head) containing lamin 5
 
9
 
 sequences, 12 codons of myc se-
quence, and the entire NF-L 3
 
9
 
 region (Monteiro et al., 1994) was intro-
duced into the CMV expression vector. This plasmid was then double di-
gested with SacII, which is located 3
 
9
 
 of the EagI site in the 5
 
9
 
 untranslated
sequence of lamin A, together with SalI, which cleaves 5
 
9
 
 of the myc se-
quences. PS-2 fragments digested with SacII and SalI were subsequently
ligated into this CMV expression vector.
 
pPS-2
 
1
 
MYC
 
To express full-length PS-2 tagged with the myc epitope, the PS-2 cDNA
was PCR amplified with primers that introduced a SacII site upstream of
the ATG and a SalI site at the 3
 
9
 
 end, which eliminated the stop codon
and fused the protein to the myc sequence (described in Monteiro et al.,
1994). The 5
 
9
 
-end primer, 5
 
9
 
ACGTACGTAACCGCGGGTTCGTGG-
TGCTTCCAG3
 
9
 
, contained a SacII site followed by 17 bases at its 3
 
9
 
 end,
which were identical in sequence to the coding strand of PS-2 with similar-
ity beginning 10 bp upstream of the ATG start codon. The 3
 
9
 
-end PCR
primer, 5
 
9
 
TATCGCTTAAGTCGACGATGTAGAGCTGATGGG3
 
9
 
, con-
tained 17 bases complementary to sequences just upstream of the stop
codon of PS-2 and was preceded by a SalI restriction site. The 
 
z
 
1.4-kbp
PCR product was double digested with SacII and SalI and ligated into the
pGEM CMV vector (Fig. 1 
 
C
 
).
 
pPS-2
 
To express full-length PS-2 (encoding 448 amino acids [aa]; Fig. 1 
 
A
 
) that
was not myc tagged, PS-2 cloned in Bluescript and pPS-2
 
1
 
Myc were each
double digested with NotI and EcoRI. NotI cuts at codon 111 of PS-2,
whereas the EcoRI site was located downstream of the stop codon in both
plasmids. The 3
 
9
 
-end fragment of PS-2 that was devoid of myc sequences
and derived from the Bluescript vector was used to replace the corre-
sponding myc-tagged fragment in the pPS-2
 
1
 
Myc.
 
Construction of pPS-2(268aa)
 
1
 
Myc,
pPS-2(222aa)
 
1
 
Myc, and pPS-2(166aa)
 
1
 
Myc Constructs
 
To create PS-2 constructs with progressively longer COOH-terminal dele-
tions, the previously described 5
 
9
 
 primer containing the SacII site was
used in conjunction with 3
 
9
 
 primers designed to introduce SalI sites into
the PS-2 gene, which allowed the truncated proteins to be myc tagged.
 
pPS-2(268aa)
 
1
 
Myc. 
 
A 3
 
9
 
 primer, 5
 
9
 
TATCGCTTAAGTCGACCAGC-
ACAGCCACGAGAT3
 
9
 
, containing 17 bases homologous and comple-
mentary to sequences upstream of codon 268 was used to generate con-
struct pPS-2(268aa)
 
1
 
Myc using essentially the same procedure previously
described for the construction of pPS-2-Myc. This construct is deleted of
180 COOH-terminal residues immediately 3
 
9
 
 of the sixth putative TMD,
thereby removing the large hydrophilic loop and all COOH-terminal se-
quences (Fig. 1 
 
D
 
).
 
pPS-2(222aa)
 
1
 
Myc. 
 
By a similar PCR procedure, 226 residues from the
COOH terminus of PS-2 were deleted using a 3
 
9
 
 primer, 5
 
9
 
TATCGCTTA-
AGTCGACCTTCCAGTGGATGCACA3
 
9
 
, which contained 17 bases
homologous and complementary to sequences upstream of codon 222.
The resulting construct pPS-2(222aa)
 
1
 
Myc is therefore deleted of PS-2
sequences beginning three residues downstream of TMD 4 (Fig. 1 
 
E
 
).
 
pPS-2(166aa)
 
1
 
Myc. 
 
Similarly, the primer 5
 
9
 
TATCGCTTAAGTCGA-
CCTTGATGCAGCGGTACT3
 
9
 
, of which the last 17 bases were homolo-
gous and complementary to sequences upstream of codon 166 of PS-2,
deleted 282 aa beginning six residues downstream of TMD2 (Fig. 1 
 
F
 
). 
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pPS-2(138aa)
 
1
 
Myc. 
 
Primer 5
 
9
 
ACGTACGTAAGTCGACGGAGTT-
GAGGAGGCGCT3
 
9
 
, of which the last 17 bases were homologous and
complementary to sequences upstream of codon 138 of PS-2, was similarly
used to delete 310 COOH-terminal residues of PS-2, including TMD2
(Fig. 1 
 
G
 
).
 
pGFP-PS-2 and pGFP–PS-2(Asn141Ile)
 
To monitor PS-2 expression in living cells, PS-2 was cloned into the
CLONTECH pEGFP-C1 expression vector, thus fusing PS-2 to the
COOH-terminal end of 
 
Aequorea victoria
 
 GFP. To generate this clone, a
5
 
9
 
 primer, 5
 
9
 
TCCGGACTCAGATCTCTCACATTCATGGCCTCT3
 
9
 
, of
which the last 18 bp were identical to sequences starting at codon 2 of PS-2,
was used in combination with the 3
 
9
 
 primer, 5
 
9
 
TATCGCTTAAGTC-
GACGATGTAGAGCTGATGGG3
 
9
 
 (described above), to PCR amplify
PS-2 clone in Bluescript. The 
 
z
 
1.4-kbp product was digested with BglII,
which was introduced by the 5
 
9
 
-end primer, and HindIII, which cuts
PS-2 internally. The 
 
z
 
1-kbp fragment was then ligated between the BglII-
HindIII sites of pEGFP-C1. The recombinant pGFP–PS-2(
 
D
 
86) missing
86 COOH-terminal residues of PS-2 was then digested with HindIII and
EcoRI, the latter cutting 3
 
9
 
 of the former. In conjunction, PS-2 in Blue-
script was digested with the same enzymes, and the fragment containing
the 3
 
9
 
 coding sequences of PS-2 was ligated with the pGFP–PS-2(
 
D
 
86)
plasmid fragment. The resulting recombinant yielded pGFP–PS-2 corre-
sponding to full-length PS-2 (missing only the start methionine residue)
fused in frame COOH-terminal of GFP (Fig. 1 
 
H
 
).
An additional GFP–PS-2 fusion construct was made to express the PS-
2(Asn141Ile) AD-associated mutation (Levy-Lahad et al., 1995
 
a
 
; Rogaev
et al., 1995). The asparagine codon at position 141 in PS-2 was converted
to an isoleucine by a two-step PCR amplification protocol. In the first
step, the 5
 
9
 
 portion of PS-2 was amplified using the 5
 
9
 
 BglII-containing
primer described above in conjunction with a 3
 
9
 
 primer, 5
 
9
 
CGTAAC-
GCGAATTCAGGAGGCGCTGGCCCACC3
 
9
 
. The remaining PS-2 3
 
9
 
segment was amplified with a 5
 
9
 
 primer, 5
 
9
 
TCAAGCTTGAATTCCGTG-
CTGATCACCCTCATCATGATCA3
 
9
 
, and the PS-2 3
 
9
 
-end primer de-
scribed initially. Both PCR products were cut with EcoRI, which was in-
troduced by the new primers, and the segments linked in frame with GFP
to yield pGFP–PS-2(N141I) (Fig. 1 
 
I
 
). This and the other clones that were
generated by PCR were sequenced and were found to encode the ex-
pected changes.
 
pPS-2–(N141I)
 
To express full-length PS-2 containing the AD-associated mutation, PS-
2(N141I), which was neither tagged with GFP nor myc sequences (Fig. 1 B),
the XmaI-HindIII fragment from pPS-2 spanning the Asn codon at 141 of
wild-type PS-2 was replaced with the corresponding fragment containing
the mutation from pGFP–PS-2(N141I) to yield pPS-2(N141I) (Fig. 1 B).
pKv1.41Myc
A human fetal brain cDNA library (CLONTECH Laboratories, Inc.) was
screened by DNA hybridization with a 1.5-kbp EcoRV-EcoRI subfrag-
ment of human heart potassium channel Kv1.4 cDNA (kindly provided by
Dr. M. Tamkun, Vanderbilt University, Nashville, TN). One positive clone,
containing a 3,023-bp cDNA, was fully sequenced and had an open read-
ing frame of 653 amino acids that was homologous to potassium channel
Kv1.4 (Tamkun et al., 1991). Through a series of cloning steps, the cDNA
was inserted into the modified CMV expression construct, described
above, such that the cDNA was fused in-frame at codon 653 of its open
reading frame with the myc tag for expression. Transfection of this con-
struct into HeLa cells and electrophysiological recordings using the whole
cell patch clamp technique revealed classical voltage-gated activation and
inactivation kinetics of an A-type potassium channel.
Expression of Glutathione-S-Transferase (GST)–PS-2 
Fusion Proteins in Bacteria
Three different portions of PS-2, the NH2-terminal, the loop spanning
TMD 6 and 7, and the COOH-terminal regions (see Fig. 1), were ex-
pressed as GST fusion proteins in bacteria. To express the PS-2 NH2-ter-
minal sequences, the segment encoding the first 86 residues of PS-2 were
PCR amplified with a 59 primer, CGTACGTCGAATTCCCAATGCT-
CACATTCATGGC, which introduced an EcoRI site and a proline codon
one amino acid upstream of the PS-2 start codon, and a 33 bp 39 primer,
GCTGAGTACGCTCGAGCTTCGCTCCGTATTTGA, which intro-
duced a XhoI site after residue 86. Similarly, the segment encoding 120
amino acids of the loop sequence, from residue 270 to residue 389, were
PCR amplified with a 59 primer, CGCTTCTGGAATTCCCCAAAGGG-
CCTCTGAG, which introduced an EcoRI site before residue 270, and a
39 primer, GCTGAGTACGCTCGAGCAGCGTGGTATTCCAGT, which
introduced an XhoI site after residue 389.
The COOH-terminal segment encoding the last 39 PS-2 residues was
amplified with a 28-bp 59 primer, CGGTACGTGAATTCAAGAAG-
GCGCTGCC, which introduced an EcoRI site before residue 410 and the
previously described 39 primer used to introduce a SalI site into the end of
full-length PS2 to myc tag it.
The z260-bp NH2-terminal and 360-bp loop PCR products and the
Pharmacia pGST/His T1 vector (Pharmacia Biotech, Inc., Piscataway, NJ)
were all digested with EcoRI and XhoI. The z120-bp COOH-terminal PCR
fragment was cut with EcoRI and SalI. The fragments were all ligated into
pGST/His T1 with the COOH-terminal insertion destroying the XhoI site.
These ligations resulted in the fusion of PS-2 sequences COOH-terminal
and in-frame with GST. The resulting recombinant plasmids were trans-
formed into CAG456 bacteria (Mercy et al., 1992) and grown overnight at
308C in 30 ml of standard Luria Broth containing 50 mg ampicillin per ml.
The cultures were then diluted into 500 ml of fresh medium and grown for
a further 2 h. IPTG was then added to 0.1 mM, and the cultures grown for
3–4 h. The bacteria were collected by centrifugation for 30 min at 3,000 g
Figure 1. Schematic drawings of PS-2 expression constructs. The
putative structure of PS-2 is shown. The schematic with a corre-
sponding line drawing illustrates PS-2 with eight TMDs (num-
bered 1–8). NH2-, COOH-terminal, and the large hydrophilic loop
domains are all present on the cytoplasmic side of an ER mem-
brane. (A–I) PS-2 expression constructs used in this study. Some
of the restriction sites used for cloning are shown. Transcription
of all constructs was driven by the CMV promoter. The con-
structs that were myc- or GFP-tagged are illustrated. Constructs
B and I contain the AD-associated PS-2(N141I) mutation. Con-
struct J is a line drawing of the Kv1.4 human potassium channel
cDNA that was used as a control since it is similar in topology
(shown schematically) to PS-2.The Journal of Cell Biology, Volume 139, 1997 488
and resuspended in 1/10 vol chilled 50 mM Tris, pH 7.5, 10% sucrose solu-
tion. The following steps were all done on ice: Lysozyme was added to 0.2
mg/ml and left for 20 min with occasional mixing followed by EDTA to 5
mM, NP-40 to 0.1%, and sarkosyl to 0.25%. After a 10-min incubation on
ice, the lysed bacteria were sonicated and spun at 48C for 30 min at 30,000 g.
The pellet was removed and the soluble bacterial proteins were incubated
for 17 h on a rocker with swollen and equilibrated glutathione agarose
beads (Sigma Chemical Co., St. Louis, MO). The slurry was centrifuged at
3,000 g for 5 min, the supernatant was removed, and the agarose pellet
was washed in chilled PBS five or six times. GST fusion proteins were
eluted in batch with four consecutive bed volume elutions of 10 mM re-
duced glutathione in 50 mM Tris, pH 8. The eluted fractions were dialyzed
in 50 mM Tris, pH 7.5, 10% sucrose, and 5 mM EDTA. The purified pro-
teins and soluble fractions, together with soluble fractions of IPTG-
induced bacteria, were boiled in Laemmli buffer and separated by SDS-
PAGE. The purified protein fractions were also used in antibody blocking
experiments.
Tissue Culture and DNA Transfection
HeLa cells were grown in DME supplemented with 10% FBS (Monteiro
and Mical, 1996). Exponentially growing cells were transfected with 10–20
mg of plasmid DNAs as calcium phosphate precipitates (Graham and van
der Eb, 1973).
Staining of Cells and Analysis by Immunofluorescence 
Light Microscopy
For immunofluorescence microscopy, cells were transfected directly on
glass coverslips. At various times after transfection, the coverslips were
fixed in 1% paraformaldehyde on ice for 15 min and then immersed in
2208C 70% ethanol for 20 min or overnight. The cells on the coverslips
were rehydrated in PBS, blocked in 0.8% BSA, stained with primary and
secondary antibodies, and finally stained with 1 mg/ml 496-diamidino-
2-phenylindole (DAPI) as previously described (Monteiro et al., 1994).
The primary antibodies used were the mouse monoclonal anti–myc 9E10
antibody (Monteiro et al., 1994), a goat polyclonal anti–PS-2 antibody
generated using a 20-aa peptide corresponding to NH2-terminal sequences
for PS-2 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), a rabbit poly-
clonal anti-GFP antibody (CLONTECH Laboratories, Inc.), a rabbit
polyclonal anticalreticulin (StressGen, Victoria, Canada), and a rabbit
polyclonal antilamin antibody generated against purified bacterially ex-
pressed human lamin C. For antibody–ligand competition experiments,
the goat anti–PS-2 antibody diluted 1:150 was incubated overnight with
equal molar amounts (z250 mg) of either bacterially purified GST protein
or the GST–NH2-terminal PS-2 fusion protein before application to the
transfected coverslips. Secondary antibodies used were affinity purified
fluorescein- or rhodamine-conjugated rabbit anti–mouse, rabbit anti–
goat, donkey anti–rabbit, donkey anti–goat, goat anti–mouse, and goat
anti–rabbit antibodies (Jackson ImmunoResearch Laboratories, Inc.,
West Grove, PA). Fluorescence staining and phase contrast images of cells
were visualized on an inverted Zeiss Axiovert 135 microscope (Thorn-
wood, NY). Images were captured either on 35-mm TMAX 400 profes-
sional film (Eastman Kodak Corp., Rochester, NY), or using an Image
Explorer II system incorporating a Dage MTI CCD72 camera and frame
grabber together with IPLab Spectrum software (Signal Analytics Corp.,
Vienna, VA) on a Power Macintosh (Apple Computer Co., Cupertino, CA).
Analysis of GFP Fluorescence and Visual Monitoring of 
Cell Death
HeLa cells plated on gridded coverslips (Eppendorf, Milwaukee, WI)
were transfected with GFP-expressing constructs, and at various times af-
ter transfection, the coverslips were washed with sterile PBS, and GFP flu-
orescence was visualized using the FITC filter 10 set (Carl Zeiss, Inc.).
The fluorescence and phase contrast images of transfected cells in the
same gridded areas were captured 17, 41, and 65 h after transfection using
the Image explorer II camera. After image analysis, the PBS was replaced
with fresh DMEM medium, and the coverslips were quickly returned to
the CO2 incubator.
In an alternative procedure, cell death was quantitated by counting the
number of floating cells that accumulated 20 and 44 h after transfection.
For this analysis, 1–1.5 3 105 HeLa cells grown in 100-mm dishes were
transfected with either 15 or 20 mg DNA of the various PS-2 expression
constructs. 20 h after transfection, the medium was collected from each
dish and fresh medium was added to the dishes. The number of floating
cells in medium obtained 20 and 44 h after transfection were counted us-
ing a hemacytometer. The number of floating apoptotic cells (of which 50–
60% failed to exclude trypan blue—not untypical of apoptotic cells since
loss of membrane integrity occurs very late during apoptosis) and not in-
cluding mitotic cells (distinguished by the presence of metaphase plates)
in the PS-2 transfected dishes were normalized to the number found in
mock-transfected dishes.
Protein Preparation, SDS Gel Electrophoresis,
and Immunoblotting
Cells were lysed in 0.5% SDS lysis buffer containing protease inhibitors
(Monteiro and Mical, 1996) and the unboiled lysates were analyzed on 8.5
and 10% SDS-PAGE gels (Laemmli, 1970). The gels were calibrated by
electrophoresing known molecular mass standards; rabbit muscle myosin
(205 kD), Escherichia coli b-galactosidase (116 kD), rabbit muscle phos-
phorylase B (97.4 kD), bovine albumin (66 kD), egg albumin (45 kD), and
carbonic anhydrase (29 kD) (Sigma Chemical Co.). The fractionated pro-
teins were transferred onto 0.1-mm nitrocellulose membranes (Schleicher &
Schuell, Keene, NH) by electroblotting, and immunoblots were processed
as described previously (Xiao and Monteiro, 1994).
Double Labeling of PS-2–transfected HeLa Cells
with the myc Monoclonal Antibody and Terminal 
Transferase Fluorescence In Situ
Apoptosis Detection
Transfected cells were analyzed for apoptosis using the in situ Apop Tag
detection kit (Oncor, Inc., Gaithersburg, MD) essentially as described by
the manufacturer. HeLa cells transfected on coverslips were fixed in 1%
paraformaldehyde on ice for 15 min, transferred to 0.5% Triton in PBS for
3 min, and placed in 2208C 70% ethanol for 20 min. The cells on cover-
slips were rehydrated by two incubations with PBS for 5 min each and
then transferred to a humidified chamber and covered with Equilibration
buffer (Oncor S7110 kit) for 5 min, after which the buffer was replaced
with the working strength terminal deoxynucleotide transferase enzyme.
The chamber containing the coverslips was placed in a 378C incubator,
and after 3.5 h, the coverslips were submerged in the working strength
stop/wash buffer for 0.5 h and rinsed in three changes of PBS for 3 min
each. Working strength antidigoxigenin-fluorescein was applied for 0.5 h,
and the cells were washed again first in 1% Triton in PBS for 3 min and
twice more in PBS for 5 min each. The coverslips were then counter-
stained with the myc monoclonal antibody followed by rhodamine-conju-
gated goat anti–mouse antibody as described above.
Results
The First 166 Residues of PS-2 Are Sufficient for
ER Targeting
To investigate PS-2 function, full-length PS-2 and progres-
sive COOH-terminal truncations, tagged at their COOH ter-
minus with a myc epitope and under transcriptional control
of a CMV promoter (Fig. 1), were expressed in HeLa cells
by transient transfection. Immunoblot analysis of protein ly-
sates prepared from cells transfected with either myc-tagged
or nontagged full-length PS-2 contained immunoreactive
bands of z50–54 kD when probed with a polyclonal anti-
body specific for NH2-terminal PS-2 sequences (Fig. 2 C,
lanes 2 and 4, respectively) that were not detectable in
mock-transfected lysates (Fig. 2 C, lanes 1 and 3). The PS-2
antibody recognized GST fusion proteins containing NH2-
terminal but not loop or COOH-terminal PS-2 sequences
(Fig. 2, A and B). PS-2 deletions in which the COOH-ter-
minal 180, 226, and 282 residues were removed (see Fig. 1
and Materials and Methods) migrated as doublet bands in
SDS-PAGE gels (evident in shorter exposures of autora-
diographs, data not shown) with apparent molecular sizesJanicki and Monteiro Induction of Apoptosis by Presenilin 2 489
of z35–37, 33–35, and 31–33 kD, respectively (Fig. 2 C,
lanes 4–7). Apart from these bands, larger immunoreac-
tive complexes were routinely seen in PS-2–transfected
cells but not in mock-transfected cells and appeared to
represent dimers, trimers, and higher molecular mass com-
plexes of PS-2 proteins (Fig. 2 C, lanes 4–7, small arrow-
heads). We did not observe any significant proteolytic
cleavage of the PS-2–expressed products as has been pre-
viously reported (Kim et al., 1997; Tomita et al., 1997). In
fact, immunoblot analyses of a parallel gel probed with the
myc antibody, which recognized the COOH terminus of
PS-2, contained bands identical in size to those recognized
by the anti–NH2-terminal PS-2 antibody, indicating full-
length accumulation of the various PS-2 polypeptides with
the presence of both NH2- and COOH-terminal epitopes
(compare Fig. 2 C, lanes 3–7, with Fig. 2 D, lanes 1–5). The
myc-reactive PS-2 bands were clearly distinguished from
the z35 and 65 kD endogenous bands present in all HeLa
cell lysates (Fig. 2 D, small arrowhead).
Immunofluorescence staining of HeLa cells transiently
transfected with full-length myc-tagged PS-2 (pPS-21Myc)
displayed nuclear envelope and ER staining when probed
with either the anti–NH2-terminal PS-2 or myc antibodies
(Fig. 3, A and B). In fact there was complete colocalization
upon double staining with the two antibodies, corroborat-
ing the immunoblot data for lack of cleavage and separa-
tion of NH2- and COOH-terminal PS-2 epitopes. The
specificity of this double staining was demonstrated by
preincubation of the PS-2 NH2-terminal antibody with pu-
rified GST–PS-2 NH2-terminal fusion protein (shown in
Fig. 2 A, lane 6), which abolished PS-2 NH2-terminal stain-
ing almost completely, but myc staining was retained (Fig.
3, C and D, respectively). To confirm PS-2 was localized to
the ER, we double stained transfected cells for calreticu-
lin, a calcium-binding protein that is localized to the ER
(Opas et al., 1991), and for PS-2 using the NH2-terminal
antibody. Full-length myc-tagged PS-2, as well as the three
deletion constructs in which 180, 226, and 282 COOH-ter-
minal PS-2 residues were deleted, showed colocalization with
calreticulin (Fig. 3, E–H and data not shown). In contrast,
construct pPS-2(138aa)1Myc, deleted of 310 COOH-termi-
nal residues, including TMD2, did not show colocalization
with calreticulin (Fig. 3, I and J). These results indicated that
166 NH2-terminal residues of PS-2 are sufficient for ER tar-
Figure 2. Immunoblot analy-
sis of PS-2 proteins. (A and
B) PS-2 NH2-terminal, loop,
and COOH-terminal se-
quences were expressed as
GST fusion proteins and sep-
arated by SDS-PAGE on
8.5% polyacrylamide gels.
The separated proteins were
either stained with Coo-
massie blue (A) or trans-
ferred onto nitrocellulose fil-
ters and immunoblotted
with the PS-2 NH2-terminal
antibody (B). Lanes 1–4 are
whole cell lysates of bacteria
induced for expression of
GST fusion proteins by addi-
tion of IPTG, and lanes 5–8
are the corresponding puri-
fied GST fusion proteins.
The GST fusion proteins that
were expressed are as fol-
lows: Lanes 1 and 5, GST
alone; lanes 2 and 6, GST–
NH2-terminal fusion protein;
lanes 3 and 7, GST–loop fu-
sion protein; and lanes 4 and
8, GST–COOH-terminal fu-
sion protein. The arrowheads
indicate the position of full-length GST fusion proteins. (C–F) Protein lysates of transfected HeLa cells separated by SDS-PAGE on
8.5% gels and immunoblotted with antibodies that recognize the transfected proteins. (C) Immunoblot with the anti–PS-2–specific anti-
body. Lanes 1–7 are lysates of cells transfected with the following constructs: Lanes 1 and 3, mock-transfected cells; lane 2, pPS-2; lane
4, pPS-21Myc; lane 5, pPS-2(268aa)1Myc; lane 6, pPS-2(222aa)1Myc; and lane 7, pPS-2(166aa)1Myc. (D) Immunoblot of corre-
sponding lysates shown in C with the anti-myc antibody. Lysates in lanes 1–5 in D correspond to lysates in lanes 3–7 in C. (E) Immunoblot
with the anti–GFP-specific antibody. Lanes 1–4 are protein lysates of cells transfected with the following constructs: Lane 1, mock-
transfected cells (control); lane 2, pGFP; lane 3, pGFP–PS-2; and lane 4, pGFP–PS-2(N141I). (F) Immunoblot of nonfusion PS-2 pro-
teins with the NH2-terminal PS-2 antibody. Lanes 1–3 are 100 mg of protein lysates of cells transfected with equivalent amounts of the
following nonfusion PS-2 constructs: Lane 1, mock-transfected; lane 2, pPS-2 (wild-type); and lane 3, pPS-2(Asn141Ile) mutant. The po-
sitions of protein molecular weight markers are indicated. Full-length PS-2 containing polypeptide bands seen only in transfected cell
lysates are marked with large arrowheads. The small arrowheads indicate the positions of larger PS-2 complexes.The Journal of Cell Biology, Volume 139, 1997 490
geting. Since pPS-2(138aa)1Myc did not localize correctly
to the ER, it was not studied further.
PS-2 Expression in HeLa Cells Causes Abnormal 
Nuclear Morphology
An obvious consequence of increased synthesis of PS-2 in
transfected HeLa cells was the development of abnormal
nuclear morphologies. An examination of PS-2 staining,
DNA staining, and the phase contrast images of cells ex-
pressing full-length PS-21myc and the three PS-2 deletion
mutants 24 h after transfection, clearly revealed that PS-2
expression results in abnormal changes in nuclear shape
(Fig. 4, A–F, and data not shown). For example, in Fig. 4
A, the two positively stained PS-2–transfected cells have
condensed and shrunken nuclei compared to the untrans-
fected cells in the same field. Interestingly, the change in
nuclear morphology appeared to correlate with the amount
of PS-2 protein expressed as revealed by differences in the
staining intensity. These features were consistently seen in
PS-2–overexpressing cells but not in mock-transfected con-
trols and HeLa cells transfected with lamin or potassium
channel cDNAs (Fig. 4, G–I). The overt changes in nuclear
morphology were therefore not simply due to the overex-
pression of a protein targeted to the nuclear envelope, as
in the case of lamins, or a transmembrane protein since the
Kv1.4 channel has almost the same number of transmem-
brane domains and has a general topology to that of the
presenilins (see Fig. 1).
The rate at which nuclear changes became apparent was
construct dependent, with pPS-21Myc, pPS-2(268aa)1
Myc, and pPS-2(222aa)1Myc all causing more rapid changes
than pPS-2(166aa)1Myc–transfected cells. This time-depen-
dent change in nuclear morphology correlated with an in-
crease in floating dead cells in the medium. Quantification
of the rate of cell death induced by the different PS-2 con-
structs 20 and 44 h after transfection revealed that pPS-
21Myc, pPS-2(268aa)1Myc, and pPS-2(222aa)1Myc kill
cells at similar rates (Fig. 5 A). In contrast, in cells trans-
fected with PS-2(166aa)1Myc this rate was reduced z70%
20 h after transfection, but by 44 h it had accelerated and
approached that of the other constructs (Fig. 5 A).
Abnormal Nuclear Morphology as a Consequence of 
PS-2 Expression Correlates with Death of HeLa Cells 
by Apoptosis
The striking changes seen in PS-2–transfected cells were
reminiscent of the nuclear and morphological changes that
occur during programmed cell death, or apoptosis (Wyllie,
1980; Earnshaw, 1995). To investigate if the cells were in-
deed dying by apoptosis, we used the terminal deoxynucle-
otide transferase nick end labeling (TUNEL) assay to iden-
tify apoptotic cells. HeLa cells transfected with pPS-2
(166aa)1Myc offered an unusual opportunity to deter-
mine if the putative dying cells could be TUNEL labeled
since they manifested and displayed the morphological
features of apoptosis over a prolonged time period and the
expressed cells adhered to the coverslips up until 40 h after
transfection. In contrast, we were unable to TUNEL label
cells transfected with full-length PS-2 since most of the
transfected cells had lifted off of the coverslips by 18–24 h
after transfection, probably as a consequence of a faster
Figure 3. Immunofluorescence localization of PS-2 proteins in
HeLa cells. (A–D) HeLa cells transiently transfected with PS-21
Myc and stained for PS-2 expression using antibodies specific for
either the PS-2 NH2 terminus (A and C) or the myc tag at the
COOH terminus (B and D). The anti–PS-2 antibody was preincu-
bated with either purified GST nonfusion protein for A and B or
GST–NH2-terminal fusion protein for C and D to demonstrate
specificity of the anti–PS-2 NH2-terminal antibody. Double stain-
ing of the transfected cells with the preincubated PS-2 and anti-
myc antibodies demonstrate that staining is abolished only upon
incubation with GST fusion proteins containing NH2-terminal PS-2
sequences. Staining for both NH2- and COOH-terminal epitopes
showed complete colocalization (compare A and B), suggesting
the two epitopes are not dissociated (not proteolytically cleaved
and differentially localized). (E–J) HeLa cells transiently trans-
fected with constructs pPS-21Myc (E and F), pPS-2(166aa)1Myc
(G and H), and pPS-2(138aa)1Myc (I and J) and double stained
for PS-2 and calreticulin. The left and right panels show the same
cells double-stained for either PS-2 expression, using the anti–
NH2-terminal PS-2 antibody (E, G, and I), or for endogenous cal-
reticulin (F, H, and J). Please note complete colocalization of PS
staining with calreticulin in pPS-21Myc– and pPS-2(166aa)1Myc–
expressing cells but not with pPS-2(138aa)1Myc–transfected cells.
Bar, 10 mm.Janicki and Monteiro Induction of Apoptosis by Presenilin 2 491
death rate and the multiple washing steps used in the
TUNEL assay.
Fig. 6, A–D, shows a typical example of PS-2(166aa)1
Myc–transfected cells in which TUNEL-positive labeling
(Fig. 6 B) correlated with PS-2 expression (Fig. 6 A). Inter-
estingly, only the highly condensed nuclei of the rounded-
up shrunken cells that appear about to detach from the
coverslip (seen by the phase contrast image; Fig. 6 D, ar-
rowheads) were prominently labeled. Even the PS-2–posi-
tive cell with the multiple compacted DNA aggregates, seen
by DAPI staining (Fig. 6 C), was not TUNEL labeled, sug-
gesting that it is an earlier stage of apoptosis during which
few free DNA 39 ends have been generated or are accessi-
ble for labeling. In addition to DNA cleavage, another fea-
ture of cells undergoing apoptosis is the collapse of the nu-
clear envelope and cleavage of lamin proteins (Kaufmann,
1989; Ucker et al., 1992; Oberhammer et al., 1994; Lazeb-
nik et al., 1995; Rao et al., 1996). We therefore examined
the integrity of the nuclear lamina in pPS-2 (166aa1Myc–
transfected cells using an antibody specific for lamins A/C
(Fig. 6, E–H). In PS-2–expressing cells, the nuclear lamina
had indeed collapsed but was round and apparently nor-
mal in PS-2–negative cells. In some PS-expressing cells,
the nuclear lamina was diffuse, suggesting cleavage of the
nuclear lamins during apoptosis.
Direct Demonstration that Overexpression of PS-2 
Causes Cell Death Using GFP as a Reporter
To directly watch temporally the pathway of apoptosis, we
generated GFP fusion proteins in which PS-2 was fused in
frame to the COOH terminus of the GFP. Two different
constructs were studied. The first was pGFP–PS-2, in which
wild-type PS-2 was linked to GFP. The second was pGFP–
PS-2(N141I), containing the AD-associated PS-2 mutation
at codon 141, converting asparagine to isoleucine (Levy-
Lahad et al., 1995a; Rogaev et al., 1995). Immunoblot anal-
ysis of transfected HeLa cell lysates indicated both GFP–
PS-2 fusion proteins to migrate on SDS-PAGE as z80-kD
polypeptides (Fig. 2 E), consistent with fusion of 27 kD of
GFP sequences with 50–55 kD of PS-2. There was no evi-
dence for any proteolytic cleavage of the fusion proteins.
Furthermore, both GFP–PS-2 fusion proteins displayed clas-
sical ER and nuclear envelope localization when exam-
ined by direct fluorescence microscopy (Fig. 7, A and B),
indicating that fusion of GFP with PS-2 did not noticeably
alter the normal ER localization pattern of PS-2.
HeLa cells grown on gridded coverslips were transfected
with the GFP vector lacking any insert or with the GFP–
PS-2 fusion constructs, and the effects on cell viability were
studied over time. Images of cells on different coverslip ar-
Figure 4. Overexpression of PS-2 proteins in HeLa cells leads to overt changes in nuclear morphology. HeLa cells were transfected with
pPS-21Myc (A–C), pPS-2(268aa)1Myc (D–F), or pKv1.41Myc (G–I). (A, D, and G) Anti-myc staining of cells 24 h after transfection.
The center panels are the corresponding DNA images of the cells revealed by DAPI staining, and the right panels are the phase contrast
images of the same cells. Please note that the majority of cells expressing high levels of PS-2 have dismorphic nuclei. In some of these
cells, the nuclei are highly condensed with rounded-up and shrunken cytoplasms (arrowheads).The Journal of Cell Biology, Volume 139, 1997 492
eas were recorded 17 h after transfection, and the same ar-
eas (identified by grid markings on the coverslips) were re-
examined 41 and 65 h after transfection (examples of such
fields are shown in Fig. 7 B). The number of fluorescing
cells seen 41 and 65 h after transfection were normalized
to the cell counts at 17 h. As shown in Fig. 5 B, the number
of cells expressing GFP increased z155% after 41 h and to
158% at 65 h. The initial increase at 41 h probably resulted
from either cell division of the transfected cells (the HeLa
cell cycle is z23 h; Monteiro and Mical, 1996) and/or an
increase in GFP expression in cells previously scored as
nonexpressors. The smaller increase at 65 h is probably
due to loss of transient GFP expression during prolonged
growth. In sharp contrast, cell viability dramatically de-
creased in cells expressing GFP–PS-2 fusion proteins. 41 h
after transfection, cell viability decreased to z76% in cells
expressing wild-type PS-2 fusion proteins and decreased
further to 33% by 65 h. A similar dramatic decrease in cell
viability was seen in cells expressing the PS-2(N141I) mu-
tation with viability decreasing to 74% at 41 h and 38% af-
ter 65 h. In both cases, decrease in cell viability correlated
with the appearance of numerous rounded-up shrunken
cells at the later time points, consistent with cell death by
apoptosis. However, a careful comparison of cell viability
in six sets of independent experiments and analysis of
greater than 2,000 cells indicated no significant difference
in the rate of cell survival between wild-type and mutant
PS-2 GFP fusion proteins in HeLa cells (Fig. 5 B).
The time-dependent loss of GFP fluorescence could have
resulted from the loss of transient expression or the loss of
cells from the coverslips due to death. To test these and
other possibilities, we followed individual GFP-expressing
cells over a period of time. A typical example of this analy-
sis is shown in Fig. 8, where at least three of a group of
cells attached on the No. 2 grid mark of the coverslip are
clearly seen to express the GFP–PS-2 fusion protein by
fluorescence at 22 h. After 50 h, these same cells, which
had retained some residual fluorescence, had rounded-up
and had shrunken cytoplasms typical of dying cells.
A Comparison of Nonfusion PS-2 Proteins
Indicates the AD-associated (Asn141Ile) Mutation 
Increases Cell Death
The lack of a noticeable difference in the rate of cell sur-
vival between wild-type PS-2 and the AD-associated mu-
tation when studied as GFP fusion proteins could have re-
sulted from the GFP moiety masking or interfering with
PS-2 properties. Therefore, wild-type and the AD PS-2
mutant were expressed and studied as nonfusion proteins
in HeLa cells by transient transfection of equivalent amounts
of DNA. Measurement of dead floating cells 40 h after
Figure 5. Quantitation of cell survival upon transfection of PS-2 constructs. (A) HeLa cells were transfected with 20 mg equivalents of
pPS-21Myc, pPS-2(268aa)1Myc, pPS-2(222aa)1Myc, or pPS-2(166aa)1Myc DNAs or were mock transfected, and the number of floating
cells that accumulated in the media were counted 20 and 44 h after transfection. The line graph shows the number of floating cells (dead
cells) in four separate experiments relative to that seen in control mock-transfected cells. The average error for four experiments was
z10–15% and is not included for clarity of presentation. Note, cells transfected with pPS-2(166aa)1Myc DNA displayed delayed cell
death at 20 h. (B) HeLa cells were transfected with either pGFP, pGFP-PS-2, or pGFP-PS-2(N141I), and fluorescent images of the same
coverslip areas were captured and counted 17, 41, and 65 h after transfection. The number of fluorescent cells seen at 41 and 65 h were
normalized to the numbers seen at 17 h as a means of measuring the effects of expression of the GFP constructs on cell viability. The his-
tograms show the average percentage of cell viability in six independent transfections with the GFP–PS-2 and GFP–PS-2(Ans141Ile)
constructs, and the corresponding average for three transfections with the GFP construct. (C) HeLa cells were transfected with equivalent
amounts plasmid DNA expressing either wild-type PS-2 or PS-2 containing the AD-associated mutation (N141I). The number of dead
cells was counted 40 h after transfection. The histogram shows the rates of cell death in three separate experiments using 15 mg of plas-
mid DNA relative to the number of dead cells found in the mock-transfected controls.Janicki and Monteiro Induction of Apoptosis by Presenilin 2 493
transfection indicated the mutant kills cells 1.84-fold faster
than does wild-type PS-2 (Fig. 5 C). Since the cells were
dying at different rates it was difficult to normalize trans-
fection efficiencies using unlinked reporters. However, the
mutant may be considerably more toxic than was esti-
mated by our experiments if less mutant DNA was trans-
fected since immunoblotting of equivalent protein lysates,
prepared from parallel sets of transfections 20 h after
transfection, indicated the mutant to be expressed z25%
that of wild-type protein levels (Fig. 1 F).
Discussion
The evidence presented here demonstrates that forced ex-
pression of PS-2 in HeLa cells, by itself, is sufficient to in-
duce apoptosis and that the AD-associated mutation
N141I induces an increase in cell death. Initially, it was
thought that PS-2 may inhibit apoptosis because a COOH-
terminal fragment of mouse PS-2, termed ALG-3, rescued
T cells from receptor-induced programmed cell death (Vito
et al., 1996a). More recently, the cause of this rescue has
been shown to be an artifactual consequence of expressing
a PS-2 fragment such that it acts in a dominant negative
fashion (Vito et al., 1996b). Further evidence supporting
the participation of PS-2 in apoptosis was obtained upon
expression of either wild-type or mutant PS-2(N141I) in
PC12 cells that had been triggered by external stimuli to
undergo apoptosis (Deng et al., 1996; Wolozin et al., 1996).
PS-2 expression accelerated death in these cells, with the
PS-2(N141I) mutant increasing apoptosis but only in cells
grown under certain culture conditions (Wolozin et al.,
1996). The PC12 studies offered only weak evidence for
the apoptotic property of PS-2 since the cells had been
primed to undergo apoptosis by external agents. More-
over, PC12 cells are balanced at a suicidal decision and are
particularly susceptible to induction of apoptosis by a wide
variety of stimuli. Our results showing apoptotic induction
in HeLa cells provide strong and independent evidence for
the PS-2 apoptotic property since HeLa cells are typically
highly resistant to apoptosis.
The mechanisms by which PS-2 overexpression leads to
cell death by apoptosis are not revealed by our studies. Al-
though the presenilins are ubiquitously expressed, PS-2 is
expressed at considerably lower levels than PS-1 (Rogaev
et al., 1995; Sherrington et al., 1995; Li et al., 1995; Lee et al.,
1996). Perhaps in normal cells, expression of one or both
of the presenilins is modulated by other factors that regu-
late the commitment to the cell death pathway. Presum-
ably, in the transient transfections increases in expression
of PS-2 leads to the perturbation of this regulation in favor
of the apoptotic pathway.
Although PS-1 is highly homologous to PS-2, no in-
creased apoptosis has been documented in cell lines and
transgenic mice overexpressing PS-1 (Duff et al., 1996; Ko-
vacs et al., 1996; Thinakaran et al., 1996). While the sim-
plest explanation is that PS-1 may function differently from
PS-2, another possibility is that transgenic lines overexpress-
ing PS-1 may induce compensatory changes in the expres-
sion of antiapoptotic genes. Another likely possibility is that
proteolytic cleavage of PS proteins alter their properties
significantly. Most prior reports have shown overexpres-
sion of PS proteins in cell lines and transgenic mice to yield
primarily proteolytic products. However, in our experiments
we failed to observe significant cleavage (,5–10%) of the
expressed PS-2 proteins, including those containing full-
length PS-2 sequences. Based on these observations, we
propose that proteolytic cleavage of the presenilins dimin-
ishes the apoptotic effects of the full-length proteins. That
PS truncations are less toxic than full-length proteins is
supported by higher levels of truncated proteins that accu-
mulated with increasing length of COOH-terminal trunca-
tions (see Fig. 2, C and D).
The AD-associated PS-2 mutation converting arginine
to isoleucine at codon 141 caused an increase in apoptosis
in cells overexpressing the mutant protein. Despite accu-
mulating to lower protein levels than the wild-type pro-
tein, the mutant is more toxic. The deletion studies pre-
Figure 6. Correlation of apoptotic events in HeLa cells expressing PS-2. HeLa cells were transfected with the pPS-2(166aa)1Myc con-
struct and were examined for apoptotic or morphological changes 48 h after transfection. The rows of panels are the same cells stained
for PS-2 protein (A and E), TUNEL labeling (B), or lamin staining (F); DAPI staining of DNA (C and D) and phase contrast images (D
and H). Cells that labeled positive for TUNEL appeared rounded-up and shrunken by phase contrast microscopy (arrowheads).The Journal of Cell Biology, Volume 139, 1997 494
sented here have indicated that retention of NH2-terminal
PS-2 sequences are necessary for apoptosis. Not surpris-
ingly, fusion of GFP to the NH2 terminus of PS-2 masks
these differences.
Clearly, if the differential killing effect of full-length wild-
type and mutant PS-2 is relevant to disease, then it must
manifest in neurons that are at risk in AD. Suggestive evi-
dence that apoptosis may be involved in AD is supported
by increased accumulation of the death-promoting pro-
tein, Bax, as well as increased evidence for nuclear DNA
fragmentation, in AD cases but not in controls (Su et al.,
1997). Additionally, recent reports suggest that AD muta-
tions in bAPP may also induce apoptosis when expressed
in neuronal cells and that death is mediated by heterotri-
meric guanosine triphosphate–binding proteins (G proteins;
Yamatsuji et al., 1996). Interestingly, FAD patients with
mutations in presenilin genes and transgenic mice express-
ing mutant human PS genes have elevated levels of Ab42-43
peptides (Duff et al., 1996; Scheuner et al., 1996; Borchelt
et al., 1996; Tomita et al., 1997), which have been docu-
mented to induce apoptosis (LaFerla et al., 1995). The obvi-
ous implications of all of this is that missense mutations in
presenilins produce subtle effects that increase apoptosis
over the course of the neuronal life span.
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